FDA
approval
· 2009-11-16
FDA Approved: QUTENZA — Original Application (Averitas Pharma Inc)
Summary
FDA approved QUTENZA (capsaicin) 8% patch from Averitas Pharma Inc in its original application for the treatment of postherpetic neuralgia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for QUTENZA (CAPSAICIN)